|
|
|
|
|
|
|
|
|
|
|
Kidney disease research in Scotland set to benefit from new deal with AstraZeneca
|
Research into three potential new medicines which can slow down the progress of chronic kidney disease and reduce the risk that patients require a transplant or dialysis will be backed by a new investment from AstraZeneca. The Scottish Government said a "triple helix" partnership between the pharmaceutical giant, NHS Scotland, and researchers based at the universities of Glasgow and Dundee will help to accelerate clinical trials into the disease.
|
|
|
|
|
View more newsletters from The Herald
|
You are receiving this email because you signed up to the Morning Headlines newsletter from The Herald, or are receiving it as part of your registration or subscription.
|
Newsquest Media Group, 1st Floor, Chartist Tower, Upper Dock Street, Newport, Wales, NP20 1DW.
Registered no: 01676637 | VAT no: 667 8301 08. Registered in England & Wales.
|
|
|